Cellular Health Screening Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Cellular Health Screening Market Size Analysis and Top Companies

The global cellular health screening market size is expected to reach around USD 6.91 billion by 2033 from USD 3.20 billion in 2023, expanding at a CAGR of 8% from 2024 to 2033. The top compnaies operating in the cellular health screening market are Life Length, SpectraCell Laboratories, Inc., RepeatDx, Cell Science Systems, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, OPKO Health, Inc., Genova Diagnostics (GDX), Immundiagnostik AG, DNA Labs India, and Others.

Market Report Coverage

Cellular Health Screening Market Companies

• Life Length
• SpectraCell Laboratories, Inc.
• RepeatDx
• Cell Science Systems
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• OPKO Health, Inc.
• Genova Diagnostics (GDX)
• Immundiagnostik AG
• DNA Labs India

Recent Developments

• In July 2023, Regenerus Labs launched the TruAge Complete test, a sophisticated epigenetic test that provides an accurate, complete, and actionable study of a patient's biological aging and health insights.
• In April 2023, Virtua Health introduced a mobile health and cancer screening unit to increase accessibility to crucial cancer diagnostics.
• In January 2023, Atomo Diagnostics, an Australian diagnostic company, established a long-term partnership with NG Biotech SAS to produce and distribute rapid blood-based pregnancy tests for both home and professional usage in prominent markets.
• In May 2022, QIAGEN NV unveiled the QIAstat Dx Rise and enhanced panels, which feature a closed system for hands-off sample preparation and processing, offering improved convenience for users.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344